136 related articles for article (PubMed ID: 20037373)
21. Adjuvant therapy for stage II and III colorectal cancer.
de Gramont A; Tournigand C; André T; Larsen AK; Louvet C
Semin Oncol; 2007 Apr; 34(2 Suppl 1):S37-40. PubMed ID: 17449351
[TBL] [Abstract][Full Text] [Related]
22. Highlights from the 42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta, GA, June 2006.
Clin Colorectal Cancer; 2006 Jul; 6(2):109-13. PubMed ID: 16945165
[No Abstract] [Full Text] [Related]
23. [Bevacizumab (Avastin)].
Yamazaki K; Yoshino T; Boku N
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1183-91. PubMed ID: 17687199
[TBL] [Abstract][Full Text] [Related]
24. [Effective chemotherapy with bevacizumab/FOLFOX4 for neuroendocrine carcinoma of the ascending colon - a case study].
Tanabe H; Takase T; Morimoto D; Tanaka Y; Shibata A; Yaguchi T
Gan To Kagaku Ryoho; 2014 May; 41(5):661-4. PubMed ID: 24917018
[TBL] [Abstract][Full Text] [Related]
25. Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer.
Dohn LH; Jensen BV; Larsen FO
Acta Oncol; 2010 Apr; 49(3):395-6. PubMed ID: 20001495
[No Abstract] [Full Text] [Related]
26. [Development of oral drugs in the standard therapy for metastatic colorectal cancer patients].
Kato K
Nihon Rinsho; 2011 Apr; 69 Suppl 3():454-8. PubMed ID: 22214003
[No Abstract] [Full Text] [Related]
27. [A case of metastatic rectal cancer in an extremely aged patient successfully treated with mFOLFOX6 plus bevacizumab].
Yokoyama M; Urakawa M; Murakami T; Amano K; Ohsawa T; Okada N; Kumamoto K; Ishibashi K; Ishida H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2241-3. PubMed ID: 22202342
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of bevacizumab for advanced colorectal cancer].
Naito M; Hoshino S; Noda N; Nakano M; Matsuo K; Yamauchi Y; Shinohara T; Tanaka S; Yamashita Y
Gan To Kagaku Ryoho; 2010 Jan; 37(1):83-8. PubMed ID: 20087037
[TBL] [Abstract][Full Text] [Related]
29. [Up to date chemotherapy for colon cancer].
Kubota T; Wada N; Kitajima M
Nihon Shokakibyo Gakkai Zasshi; 2007 Feb; 104(2):177-85. PubMed ID: 17283411
[No Abstract] [Full Text] [Related]
30. [A case of peritoneal dissemination disappeared by CPT-11 + TS-1 combination chemotherapy].
Takemoto H; Fukunaga M; Ooshiro R; Fujishima M; Yamamoto K; Tanaka J; Kondo M; Kishimoto T; Nakayama T; Imamura H; Masutani S; Tatsuta M; Kawasaki T; Furukawa H
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1768-70. PubMed ID: 16315935
[TBL] [Abstract][Full Text] [Related]
31. Pathologic complete response to neoadjuvant FOLFOX in combination with bevacizumab in unresectable metastatic colorectal carcinoma.
Duffy A; Shia J; Huitzil-Melendez FD; Fong Y; O'Reilly EM
Clin Colorectal Cancer; 2008 Mar; 7(2):140-3. PubMed ID: 18501074
[TBL] [Abstract][Full Text] [Related]
32. [Five-Year Survival of Two Patients with Para-Aortic Lymph Node Metastasis Treated with Four FOLFOX6and Four FOLFIRI Courses in Combination with Bevacizumab].
Ohara H; Yamamoto H
Gan To Kagaku Ryoho; 2018 May; 45(5):867-870. PubMed ID: 30026454
[TBL] [Abstract][Full Text] [Related]
33. [A case of advanced gastric cancer with peritoneal metastasis successfully treated over 19 months with postoperative chemotherapy after non-curative surgery].
Sugimoto K; Takayanagi H; Karaki H; Suzuki H; Hayashi S; Yamamoto K; Yamamori H; Sugano I
Gan To Kagaku Ryoho; 2008 May; 35(5):825-7. PubMed ID: 18487922
[TBL] [Abstract][Full Text] [Related]
34. [Liver metastasis from sigmoid colon cancer showed a complete response to S-1 after recurrence with FOLFOX6 treatment].
Nobuhara Y; Kubo N; Matuoka T; Yo T
Gan To Kagaku Ryoho; 2010 Jan; 37(1):177-9. PubMed ID: 20087058
[TBL] [Abstract][Full Text] [Related]
35. Perforating dermatosis in a patient receiving bevacizumab.
Vano-Galvan S; Moreno C; Medina J; Pérez-García B; García-López JL; Jaén P
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):972-4. PubMed ID: 19470057
[No Abstract] [Full Text] [Related]
36. [A recurrence after surgery for colon cancer with metastases of the liver and periaortic lymph nodes, with CR achieved by using bevacizumab+mFOLFOX6].
Matsukawa S; Shiratori T; Kugimiya M; Matsuo S; Kaji S; Aoyama Y
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1389-91. PubMed ID: 20647734
[TBL] [Abstract][Full Text] [Related]
37. Dual biologic therapy in the first-line mCRC setting: implications of the CAIRO2 study.
Chu E
Clin Colorectal Cancer; 2008 Jul; 7(4):226. PubMed ID: 18650190
[No Abstract] [Full Text] [Related]
38. [A case of metastatic colon cancer effectively treated by XELOX and IRIS].
Nishizawa T; Kinoshita S; Sakuno T; Fujiyama Y; Kikuchi M; Kaneko H; Suzuki H; Takahashi M
Gan To Kagaku Ryoho; 2013 Jun; 40(6):807-9. PubMed ID: 23863664
[TBL] [Abstract][Full Text] [Related]
39. [A case of long-term survival of unresectable-advanced gastric cancer due to chemotherapy].
Kita K; Takahashi M; Nakano S; Akabane H; Yanagida N; Shomura H; Hanamoto T; Kuji M; Oikawa F; Miyagi H
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2281-3. PubMed ID: 20037396
[TBL] [Abstract][Full Text] [Related]
40. [Stage IV gastric cancer patient who underwent palliative gastrectomy showing complete response to induction therapy with methotrexate plus 5-fluorouracil and secondary treatment with oral TS-1].
Hiramatsu K; Mizukami Y; Momiyama M; Suzuki M; Niimi K; Nagashima T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1163-6. PubMed ID: 16121921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
